Citations

Mayo Clinic

Showing 10 of 108572 citations.

Altered thermoregulatory responses in heart failure patients exercising in the heat
Balmain, Bryce N. , Jay, Ollie , Sabapathy, Surendran , Royston, Danielle, Stewart, Glenn M. , Jayasinghe, Rohan, Morris, Norman

Physiological Reports | November 16, 2016 | Volume: 4 | Issue: 21 | Pages: No page available

10.14814/phy2.13022 | PMID 27905297 Get It

AbstractHeart failure (HF) patients appear to exhibit impaired thermoregulatory capacity during passive heating, as evidenced by diminished vascular conductance. Although some preliminary studies have described the thermoregulatory response to passive heating inHF, responses during exercise in the heat remain to be described. Therefore, the aim of this study was to compare thermoregulatory responses inHFand controls (CON) during exercise in the heat. TenHF(NYHAclasses I–II) and eightCONwere included. Core temperature (Tc), skin temperature (Tsk), and cutaneous vascular conductance (CVC) were assessed at rest and during 1 h of exercise at 60% of maximal oxygen uptake. Metabolic heat production (Hprod) and the evaporative requirements for heat balance (Ereq) were also calculated. Whole‐body sweat rate was determined from pre–post nude body mass corrected for fluid intake. WhileHprod(HF: 3.9 ± 0.9;CON: 6.4 ± 1.5 W/kg) andEreq(HF: 3.3 ± 0.9;CON: 5.6 ± 1.4 W/kg) were lower (P < 0.01) forHFcompared toCON, both groups demonstrated a similar rise inTc(HF: 0.9 ± 0.4;CON: 1.0 ± 0.3°C). Despite this similar rise inTc,Tsk(HF: 1.6 ± 0.7;CON: 2.7 ± 1.2°C), and the elevation inCVC(HF: 1.4 ± 1.0;CON: 3.0 ± 1.2 au/mmHg) was lower (P < 0.05) inHFcompared toCON. Additionally, whole‐body sweat rate (HF: 0.36 ± 0.15;CON: 0.81 ± 0.39 L/h) was lower (P = 0.02) inHFcompared toCON. Patients withHFappear to be limited in their ability to manage a thermal load and distribute heat content to the body surface (i.e., skin), secondary to impaired circulation to the periphery.
Profile of cognitive impairment and underlying pathology in multiple system atrophy
Koga, Shunsuke , Parks, Adam , Uitti, Ryan J. , Gerpen, Jay A. van, Cheshire, William P. , Van Gerpen, Jay A, Wszołek, Zbigniew K. , Dickson, Dennis W. , Koga, Shunsuke , Cheshire, William P

Movement Disorders | November 16, 2016 | Volume: 32 | Issue: 3 | Pages: 405-413

10.1002/mds.26874 | PMID 27859650 Get It

ABSTRACTBackgroundThe objectives of this study were to elucidate any potential association between α‐synuclein pathology and cognitive impairment and to determine the profile of cognitive impairment in multiple system atrophy (MSA) patients. To do this, we analyzed the clinical and pathologic features in autopsy‐confirmed MSA patients.MethodsWe retrospectively reviewed medical records, including neuropsychological test data, in 102 patients with autopsy‐confirmed MSA in the Mayo Clinic brain bank. The burden of glial cytoplasmic inclusions and neuronal cytoplasmic inclusions were semiquantitatively scored in the limbic regions and middle frontal gyrus. We also assessed concurrent pathologies potentially causing dementia including Alzheimer's disease, hippocampal sclerosis, and cerebrovascular pathology.ResultsOf 102 patients, 33 (32%) were documented to have cognitive impairment. Those that received objective testing, deficits primarily in processing speed and attention/executive functions were identified, which suggests a frontal‐subcortical pattern of dysfunction. Of these 33 patients with cognitive impairment, 8 patients had concurrent pathologies of dementia. MSA patients with cognitive impairment had a greater burden of neuronal cytoplasmic inclusions in the dentate gyrus than patients without cognitive impairment, both including and excluding patients with concurrent pathologies of dementia.ConclusionsThe cognitive deficits observed in this study were more evident on neuropsychological assessment than with cognitive screens. Based on these findings, we recommend that clinicians consider more in‐depth neuropsychological assessments if patients with MSA present with cognitive complaints. Although we did not identify the correlation between cognitive deficits and responsible neuroanatomical regions, a greater burden of neuronal cytoplasmic inclusions in the limbic regions was associated with cognitive impairment in MSA. © 2016 International Parkinson and Movement Disorder Society
Public reporting: A new threat to high‐risk patients and medical innovation
Cohoon, Kevin P. , Mack, Michael J. , Holmes, David R.

Catheterization and Cardiovascular Interventions | November 16, 2016 | Volume: 89 | Issue: 2 | Pages: 335-337

10.1002/ccd.26841 | PMID 27862845 Get It

The impact of health insurance on cancer care in disadvantaged communities
Abdelsattar, Zaid M. , Hendren, Samantha , Wong, Sandra L. , Wong, Sandra

Cancer | November 16, 2016 | Volume: 123 | Issue: 7 | Pages: 1219-1227

10.1002/cncr.30431 | PMID 27859019 Get It

BACKGROUND Individuals from disadvantaged communities are among the millions of uninsured Americans gaining insurance under the Affordable Care Act. The extent to which health insurance can mitigate the effects of the social determinants of health on cancer care is unknown. METHODS This study linked the Surveillance, Epidemiology, and End Results registries to US Census data to study patients diagnosed with the 4 leading causes of cancer deaths between 2007 and 2011. A county‐level social determinant score was developed with 5 measures of wealth, education, and employment. Patients were stratified into quintiles, with the lowest quintile representing the most disadvantaged communities. Logistic regression and Cox proportional hazards models were used to estimate associations and cancer‐specific survival. RESULTS A total of 364,507 patients aged 18 to 64 years were identified (134,105 with breast cancer, 106,914 with prostate cancer, 62,606 with lung cancer, and 60,882 with colorectal cancer). Overall, patients from the most disadvantaged communities (median household income, $42,885; patients below the poverty level, 22%; patients completing college, 17%) were more likely to present with distant disease (odds ratio, 1.6; P < .001) and were less likely to receive cancer‐directed surgery (odds ratio, 0.8; P < .001) than the least disadvantaged communities (median income, $78,249; patients below the poverty level, 9%; patients completing college, 42%). The differences persisted across quintiles regardless of the insurance status. The effect of having insurance on cancer‐specific survival was more pronounced in disadvantaged communities (relative benefit at 3 years, 40% vs 31%). However, it did not fully mitigate the effect of social determinants on mortality (hazard ratio, 0.75 vs 0.68; P < .001). CONCLUSIONS Cancer patients from disadvantaged communities benefit most from health insurance, and there is a reduction in disparities in outcome. However, the gap produced by social determinants of health cannot be bridged by insurance alone. Cancer 2017;123:1219–1227. © 2016 American Cancer Society .
C1 Myelitis Presenting With Neuralgic Otalgia
Martinez‐Thompson, Jennifer M. , Garza, Ivan , Cutrer, F. Michael , Robertson, Carrie E. , Robertson, Carrie E

Headache: The Journal of Head and Face Pain | November 16, 2016 | Volume: 57 | Issue: 1 | Pages: 126-127

10.1111/head.12988 | PMID 27861805 Get It

Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer
Samson, Adel , Bentham, Matthew, Scott, Karen J. , Nuovo, Gerard J., Bloy, Abigail, Appleton, Elizabeth , Adair, Robert A, Dave, Rajiv , Toogood, Giles J. , Nagamori, Seishi, Coffey, Matthew, Vile, Richard G. , Harrington, Kevin J. , Selby, Peter J. , Errington‐Mais, Fiona , Melcher, Alan , Griffin, Stephen , Griffin, Stephen , Adair, Robert A, Peckham-Cooper, Adam , Errington-Mais, Fiona , Melcher, Alan A , Harrington, Kevin , Dave, Rajiv V , Appleton, Elizabeth

Gut | November 16, 2016 | Volume: 67 | Issue: 3 | Pages: 562-573

10.1136/gutjnl-2016-312009 | PMID 27902444 Get It

Objective Oncolytic viruses (OVs) represent promising, proinflammatory cancer treatments. Here, we explored whether OV-induced innate immune responses could simultaneously inhibit HCV while suppressing hepatocellular carcinoma (HCC). Furthermore, we extended this exemplar to other models of virus-associated cancer. Design and results Clinical grade oncolytic orthoreovirus (Reo) elicited innate immune activation within primary human liver tissue in the absence of cytotoxicity and independently of viral genome replication. As well as achieving therapy in preclinical models of HCC through the activation of innate degranulating immune cells, Reo-induced cytokine responses efficiently suppressed HCV replication both in vitro and in vivo. Furthermore, Reo-induced innate responses were also effective against models of HBV-associated HCC, as well as an alternative endogenous model of Epstein–Barr virus-associated lymphoma. Interestingly, Reo appeared superior to the majority of OVs in its ability to elicit innate inflammatory responses from primary liver tissue. Conclusions We propose that Reo and other select proinflammatory OV may be used in the treatment of multiple cancers associated with oncogenic virus infections, simultaneously reducing both virus-associated oncogenic drive and tumour burden. In the case of HCV-associated HCC (HCV-HCC), Reo should be considered as an alternative agent to supplement and support current HCV-HCC therapies, particularly in those countries where access to new HCV antiviral treatments may be limited.
Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal Disease
Chen, Yang , Burnett, John C.

Clinical Chemistry | November 16, 2016 | Volume: 63 | Issue: 1 | Pages: 108-115

10.1373/clinchem.2016.262907 | PMID 28062615 Get It

Abstract BACKGROUND Neprilysin (NEP) is a membrane-bound neutral endopeptidase that degrades a variety of bioactive peptides. The substrates include natriuretic peptides (NPs), which are important regulating mediators for cardiovascular and renal biology. Inhibition of NEP activity and exogenous NP administration thus have emerged as potential therapeutic strategies for treating cardiorenal diseases. More recently, B-type natriuretic peptide (BNP) or N-terminal-proBNP (NT-proBNP), 3′-5′ cyclic guanosine monophosphate (cGMP), and soluble NEP as biomarkers have also been investigated in heart failure (HF) trials and their predictive value are beginning to be recognized. CONTENT The biological functions of NEP and NPs are discussed. Enhancing NPs through NEP inhibition combined with renin–angiotensin–aldosterone system (RAAS) antagonism has proved to be successful in HF treatment, although future surveillance studies will be required. Direct NP enhancement through peptide delivery may have fewer potentially hazardous effects compared to NEP inhibition. Strategies of combined inhibition on NEP with other cardiorenal pathophysiological pathways are promising. Finally, monitoring BNP/NT-proBNP/cGMP concentrations during NEP inhibition treatment may provide supplemental benefits to conventional biomarkers, and the identification of soluble NEP as a novel biomarker for HF needs further investigation. SUMMARY In this review, the biology of NEP is summarized, with a focus on NP regulation. The degradation of NPs by NEP provides the rationale for NEP inhibition as a strategy for cardiorenal disease treatment. We also describe the current therapeutic strategies of NEP inhibition and NP therapeutics in cardiorenal diseases. Moreover, the discovery of its circulating form, soluble NEP, as a biomarker is also discussed.
Magnetic resonance elastography (MRE) of the human brain: technique, findings and clinical applications
Hiscox, Lucy V. , McGarry, Matt D J, Starr, John M. , Roberts, Neil , Johnson, Curtis L. , Barnhill, Eric , McGarry, Matthew D. J. , Huston, John , Beek, Edwin J.R. van

Physics in Medicine & Biology | November 15, 2016 | Volume: 61 | Issue: 24 | Pages: R401-R437

10.1088/0031-9155/61/24/r401 | PMID 27845941 Get It

Abstract Neurological disorders are one of the most important public health concerns in developed countries. Established brain imaging techniques such as magnetic resonance imaging (MRI) and x-ray computerised tomography (CT) have been essential in the identification and diagnosis of a wide range of disorders, although usually are insufficient in sensitivity for detecting subtle pathological alterations to the brain prior to the onset of clinical symptoms—at a time when prognosis for treatment is more favourable. The mechanical properties of biological tissue provide information related to the strength and integrity of the cellular microstructure. In recent years, mechanical properties of the brain have been visualised and measured non-invasively with magnetic resonance elastography (MRE), a particularly sensitive medical imaging technique that may increase the potential for early diagnosis. This review begins with an introduction to the various methods used for the acquisition and analysis of MRE data. A systematic literature search is then conducted to identify studies that have specifically utilised MRE to investigate the human brain. Through the conversion of MRE-derived measurements to shear stiffness (kPa) and, where possible, the loss tangent (rad), a summary of results for global brain tissue and grey and white matter across studies is provided for healthy participants, as potential baseline values to be used in future clinical investigations. In addition, the extent to which MRE has revealed significant alterations to the brain in patients with neurological disorders is assessed and discussed in terms of known pathophysiology. The review concludes by predicting the trends for future MRE research and applications in neuroscience.
Peptide Spectrum Matching via Database Search and Spectral Library Search
Netzel, Brian C., Dasari, Surendra

Proteome Informatics | November 15, 2016 | Volume: No volume available | Issue: No issue available | Pages: 39-68

10.1039/9781782626732-00039 Get It

High-throughput shotgun proteomics is the mainstay of protein identification in biological samples. Efficient proteomic analysis requires streamlined and accurate workflows for protein identification. Database searching has been the most basic and reliable workflow for identifying the peptides and proteins that are present in the sample. This method derives peptides from a list of protein sequences and matches them against the experimental MS2 spectra. The resulting peptide spectrum matches are scored to quantify their goodness of fit. Spectral library searching has been recently developed as a fast, and viable, alternative to sequence database searching. This method attempts to identify the peptides by matching their corresponding experimental MS2 spectra to a library of curated MS2 peptide spectra. Each method has its own merit and application in the proteomics field. This chapter aims to highlight the foundations of peptide spectrum matching via protein sequence database and spectral library searching.
Metoprolol Dose Equivalence in Adult Men and Women Based on Gender Differences: Pharmacokinetic Modeling and Simulations
Eugene, Andy, Eugene, Andy

Medical Sciences | November 15, 2016 | Volume: 4 | Issue: 4 | Pages: 18

10.3390/medsci4040018 | PMID 28035289 Get It

Recent meta-analyses and publications over the past 15 years have provided evidence showing there are considerable gender differences in the pharmacokinetics of metoprolol. Throughout this time, there have not been any research articles proposing a gender stratified dose-adjustment resulting in an equivalent total drug exposure. Metoprolol pharmacokinetic data was obtained from a previous publication. Data was modeled using nonlinear mixed effect modeling using the MONOLIX software package to quantify metoprolol concentration–time data. Gender-stratified dosing simulations were conducted to identify equivalent total drug exposure based on a 100 mg dose in adults. Based on the pharmacokinetic modeling and simulations, a 50 mg dose in adult women provides an approximately similar metoprolol drug exposure to a 100 mg dose in adult men.